Stocks of pharmaceutical industry skid

Published: 2006-06-14 06:56:00

Updated: 2006-06-14 06:56:00

The recent bioequivalence testing scandal and the U.S.'s pressure on Korea's drug pricing in the health insurance system through free trade agreement have dealt a severe blow to share prices of major pharmaceutical companies for the last two months.

Dong-A Pharm dropped 16 percent to 51,600 wo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK